CONTEGRA PULMONARY VALVED CONDUIT - SUPPORTED 200S

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2020-01-06 for CONTEGRA PULMONARY VALVED CONDUIT - SUPPORTED 200S manufactured by Medtronic Heart Valves Division.

Event Text Entries

[185074485] Citation: talwar s et al. Surgical repair for common arterial trunk with pulmonary dominance, hypoplasia of ascending aorta, and interrupted aortic arch. Annals of pediatric cardiology. 2019; 12(3):287-291. Doi: 10. 4103/apc. Apc_147_18 earliest date of publish used for event date in b3. No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported. Without return of the product no definitive conclusion can be made regarding the clinical observations. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[185074486] Medtronic received information via literature regarding a 1-month-old male patient with respiratory distress, a common arterial trunk, hypoplasia of the ascending aorta, and an interrupted aortic arch who underwent implant of a 12mm medtronic contegra pulmonary valved conduit (no serial number provided). The implant of the contegra was intended to establish continuity between the right ventricle and pulmonary artery as part of a larger repair of the aortic arch and multiple other vessels. It was reported that 8 hours post procedure, the patient experienced sudden bradycardia and hypotension. Cardiopulmonary resuscitation (cpr) was immediately performed, and the patient was placed on extracorporeal membrane oxygenation (ecmo). Two days later, the patient was weaned from ecmo with stable hemodynamics. Ultimately, 7 days post procedure, the patient expired from sepsis. It is unknown if an autopsy was performed. Based on the available information medtronic product was not directly associated with the death.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2025587-2020-00049
MDR Report Key9555847
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2020-01-06
Date of Report2020-01-06
Date of Event2019-08-21
Date Mfgr Received2019-12-11
Date Added to Maude2020-01-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactPAULA BIXBY
Manufacturer Street8200 CORAL SEA STREET NE
Manufacturer CityMOUNDS VIEW MN 55112
Manufacturer CountryUS
Manufacturer Postal55112
Manufacturer Phone7635055378
Manufacturer G1MEDTRONIC HEART VALVES DIVISION
Manufacturer Street1851 E DEERE AVE
Manufacturer CitySANTA ANA CA 92705
Manufacturer CountryUS
Manufacturer Postal Code92705
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCONTEGRA PULMONARY VALVED CONDUIT - SUPPORTED
Generic NameCONDUIT,VALVED,PULMONIC
Product CodeMWH
Date Received2020-01-06
Model Number200S
Catalog Number200S
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC HEART VALVES DIVISION
Manufacturer Address1851 E DEERE AVE SANTA ANA CA 92705 US 92705


Patients

Patient NumberTreatmentOutcomeDate
101. Life Threatening; 2. Required No Informationntervention 2020-01-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.